Digitisation | April 04, 2024
Aurigene introduces AI/ML assisted drug discovery platform
Aurigene.AI is an end-to-end solution for small molecule drug discovery
Aurigene.AI is an end-to-end solution for small molecule drug discovery
New leadership team announced at NATHEALTH Annual General Meeting 2024
Usnoflast (ZYIL1) is a novel oral small molecule NLRP3 inhibitor discovered at Zydus
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
Anand is committed to leading the company's continued commitment to driving innovation in Health Care through the utilization of Digital transformation, AI and LLM
The institution will be spread over an area of more than 8 acres
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
The investment will catalyse various components of the IndiaAI Mission
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Subscribe To Our Newsletter & Stay Updated
